NFE2L2 and chronic kidney disease: Our network pharmacology analysis indicates that oxidative stress regulation is the core mechanism by which AST exerts its renal protective effect in chronic kidney disease, and the Nrf2/HO-1 axis becomes the key pathway of this mechanism.